REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio De Patologia Y Citologia Alhumed Ltda. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio De Patologia Y Citologia Alhumed Ltda. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio De Patologia Y Citologia Alhumed Ltda. is a company based in Colombia, with its head office in Riohacha. The enterprise currently operates in the Diagnostic Imaging Centers sector. The company was established on July 11, 2007. In its most recent financial highlights, the company reported a net sales revenue increase of 28.15% in 2023. Its’ total assets recorded a negative growth of 0.6%. The net profit margin of Laboratorio De Patologia Y Citologia Alhumed Ltda. decreased by 1.82% in 2023.

Headquarters
Cl 13 Nro. 12 - 19
Riohacha; La Guajira;

Contact Details: Purchase the Laboratorio De Patologia Y Citologia Alhumed Ltda. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio De Patologia Y Citologia Alhumed Ltda. report to view the information.
Incorporation Date:
July 11, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio De Patologia Y Citologia Alhumed Ltda. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
28.15%
Total operating revenue
28.15%
Operating profit (EBIT)
20.12%
EBITDA
19.27%
Net Profit (Loss) for the Period
17.57%
Total assets
-0.6%
Total equity
-1%
Operating Profit Margin (ROS)
-1.44%
Net Profit Margin
-1.82%
Return on Equity (ROE)
7.77%
Quick Ratio
-8.09%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?